In this systematic review and meta-analysis, researchers examined outcomes among advanced ovarian cancer patients who received interval debulking surgery compared to primary debulking surgery.

Ovarian cancer often goes undetected for a long time. In seven out of 10 patients, the tumor has already formed secondary ...

Known as "the silent killer" due to its lack of symptoms and reliable screening tests, ovarian cancer remains one of the ...

High HSP60 expression in ovarian cancer is linked to poor prognosis and aggressive tumor features, including advanced FIGO stage and lymph node metastasis. Patients with elevated HSP60 levels exhibit ...

The combination of ribociclib and letrozole achieved a 30.6% objective response rate and 84% clinical benefit rate in ...

NICE has proposed age-based CA125 thresholds to improve early ovarian cancer detection while reducing unnecessary scans in ...

Fast Track designation granted by U.S. FDA for evaluation of ETX-19477 in patients with BRCA-mutated, platinum-resistant ...

Nancy Long was a gynecological nurse practitioner when she was diagnosed with ovarian cancer. Yet because the symptoms were so vague, she nearly ignored them. “I missed all the signs and symptoms of ...

Age based thresholds for blood tests to detect ovarian cancer should be introduced, the National Institute for Health and ...

A new draft NICE guideline had proposed new age thresholds to guide GP referral for ovarian cancer investigation, to improve ...

ETX-19477 is a potent, selective inhibitor of poly (ADP-ribose) glycohydrolase (PARG), an enzyme that plays a role in the DNA ...

In the PREFER trial, researchers aimed to investigate and assess the safety of strategies for fertility preservation in ...